Gene Query: RABGAP1L

Dataset Description Geneva Score
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 82.5
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 82.5
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 54.41
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 53.69
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 52.1
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 47.72
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 41.85
Lineage specific differentiation is influenced by state of human pluripotency 41.73
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 41.73
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 35.2
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 35.2
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 35.09
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 33.95
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 33.35
DIGIT regulates endoderm differentiation of human embryonic stem cells 29.37
SOX11 knockdown in B-ALL cell lines 28.76
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 28.23
Ro60-knockout cells 27.83
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 27.64
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 27.48
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 27.03
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 26.92
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 26.34
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 25.11
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 24.71
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 23.6
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 23.46
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 23.41
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 23.13
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 22.96
RNA-Seq from early time points in the kidney differentiation protocol 22.94
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 22.92
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 22.86
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 22.09
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 21.66
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 21.51
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 21.47
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 21.47
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 21.36
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 21.09
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 19.45
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 19.45
RNA sequencing analysis of human embryonic stem cells and axial progenitors 19.04
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 18.81
Effects of rFVIIIFc on human macrophages 18.62
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 18.57
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 18.57
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 18.57
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 18.52
R430: A potent inbibitor of DNA and RNA viruses 18.37
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 18.34
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 18.34
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 18.27
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 18.27
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 18.19
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 17.79
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 17.54
Differentially expressed vascular development genes for iPSC-ECs from CDI 17.5
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 17.16
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 16.99
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 16.68
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 16.67
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 16.43
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 16.43
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 16.18
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 16.12
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 16.12
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 15.86
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 15.77
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 15.77
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 15.7
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 15.7
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 15.41
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 15.35
Gene expressions of H9s in different culture systems 15.28
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 15.26
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 14.97
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 14.91
NRDE2 negatively regulates nuclear exosome functions 14.7
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 14.58
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 14.58
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 14.55
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 14.49
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 14.42
Cerebellar differentiation in Ataxia-Telangiectasia 14.38
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 14.34
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 14.12
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 13.98
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 13.92
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 13.88
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 13.87
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.86
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.86
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 13.84
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 13.76
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 13.52
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 13.52
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 13.47
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 13.43
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 13.26
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 13.17
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 12.88
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 12.71
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 12.71
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 12.69
High-throughput sequencing of PROMPT-enriched samples. 12.59
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 12.58
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 12.45
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 12.38
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 12.33
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 12.31
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 12.3
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 12.2
Global Mapping of Human RNA-RNA Interactions 12.13
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 12.11
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 12.07
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.9
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 11.89
Differentially expressed genes post knock down of lincDUSP26 11.83
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 11.74
U2AF1 mutations alter splice site recognition in hematological malignancies 11.57
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 11.57
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 11.55
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 11.55
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 11.52
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 11.52
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 11.4
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 11.31
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 11.31
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 11.27
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 11.1
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 11.07
Transcriptional profiles of normal human mature B cells 11.05
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 10.9
The role of FAM46C in myeloma cells [sequencing] 10.86
The role of FAM46C in myeloma cells 10.86
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 10.84
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 10.77
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.75
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 10.73
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 10.64
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 10.62
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 10.53
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 10.49
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 10.38
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 10.37
RNA sequencing of primary human platelets and in vitro cell lines 10.36
Transcriptome of Stabilin-1 siRNA transfected human monocytes 10.36
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.35
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 10.33
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 10.33
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 10.33
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.33
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.33
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 10.28
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 10.28
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 10.23
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 10.23
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.16
Reassessment of Exosome Composition 10.15
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 10.1
Changes in human endometrial gland transcriptome over the window of implantation 10.07
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 9.88
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 9.88
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 9.88
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 9.87
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 9.81
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 9.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 9.7
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 9.7
CHCHD10 gene KO effect in iPSC drived motor neurons 9.67
Patient-derived luminal breast cancer xenografts with progestins 9.63
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.63
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 9.62
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 9.54
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.5
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.5
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 9.4
Gene expression changes associated with resistance to tagraxofusp (SL-401) 9.39
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.36
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 9.36
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 9.35
RNA-seq analysis of RALD iPSCs after in vitro differentiation 9.32
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 9.26
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.23
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.23
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 9.12
MicroRNA-125a-5p overexpression in human macrophages 9.09
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 9.09
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 9.05
Microprocessor mediates transcription termination in long noncoding microRNA genes 9.02
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 9.0
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 9.0
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 8.86
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 8.8
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 8.73
Transcriptional responses of human insulinoma cells to acute cytokine exposure 8.71
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 8.69
Epigenomic conservation of transposable element silencing [RNA-seq] 8.69
Epigenomic conservation of transposable element silencing 8.69
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 8.68
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.67
Primary human trophoblast from term placenta 8.63
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.62
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 8.61
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 8.6
CHCHD2 gene KO effect in iPSC drived motor neurons 8.6
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 8.59
A role for ZNF598 in post-transcriptional gene regulation 8.59
MYC dependent mRNA translation shapes gene expression and cell biology 8.5
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.5
Transcription elongation regulates genome 3D structure 8.49
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.49
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.46
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 8.41
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 8.4
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.39
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 8.39
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 8.39
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 8.39
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.38
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 8.35
Human cell line and subcutaneous tumor 8.33
Transciptomic profiling of human fetal lung samples 8.3
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 8.28
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 8.27
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 8.27
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 8.26
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 8.23
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 8.22
Global gene expression profile of dasatinib-resistant RCH-ACV cells 8.17
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 8.17
Transcriptomic analysis of human tonsillar TFH subsets 8.15
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 8.1
Transcriptional landscape changes during human embryonic stem cell derivation 8.08
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 8.0
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 8.0
Macrophage Ad5f35 M2 Challenge 7.97
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 7.93
iPSC-Derived Cholangiocytes 7.92
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.91
RIG-I and MDA5 fRIP during KSHV lytic reactivation 7.9
RNA-seq of naive and primed ES cells (NHSM) 7.9
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.84
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 7.83
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 7.82
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.8
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.74
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 7.69
Disruption of GRIN2B impairs differentiation in human neurons 7.68
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 7.66
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 7.59
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 7.57
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 7.54
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.51
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 7.5
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 7.5
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 7.48
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.47
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.45
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 7.43
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 7.42
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 7.41
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 7.39
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 7.39
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 7.36
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 7.34
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 7.25
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 7.19
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.11
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 7.08
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.07
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.04
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.04
Macrophage Ad5f35 PhenoMap 7.0
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.97
AMPK signaling for naïve pluripotency [Hs] 6.92
AMPK signaling for naïve pluripotency 6.92
naive T cell heterogeneity after neonatal thymectomy 6.92
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 6.91
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 6.89
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.88
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 6.87
RNA-seq analysis of gene expression patterns during hESC neural differentiation 6.87
hESC neural differentiation 6.87
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 6.83
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 6.83
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 6.81
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 6.76
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 6.74
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 6.68
RNA sequencing with KSHV infection and enrichment for circular RNAs 6.67
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 6.66
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.61
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.58
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.57
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.51
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.51
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 6.46
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.44
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 6.42
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 6.42
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 6.32
ARS2 is a general suppressor of pervasive transcription [RNAseq] 6.25
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 6.22
Targeting MTHFD2 in Acute Myeloid Leukemia 6.16
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 6.15
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 6.07
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 6.06
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 6.05
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 6.05
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 6.03
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 6.03
Transcriptome analysis upon C6orf203 silencing 6.03
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 6.02
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 6.01
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 6.01
Comparison of microRNA Profiling Platforms (HTS) 5.94
Comparison of microRNA Profiling Platforms 5.94
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 5.93
Human Treg NaCl stimulation 5.89
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 5.82
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 5.69
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 5.69
Expression charcaterization of an internal protocol developed to differentiate RPE cells 5.63
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.6
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.6
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 5.6
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.6
Derivation and differentiation of haploid human embryonic stem cells 5.53
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 5.52
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 5.52
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 5.51
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 5.45
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 5.45
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 5.44
Loss of endometrial plasticity in recurrent pregnancy loss 5.42
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 5.42
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 5.38
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 5.38
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 5.35
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.33
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 5.31
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 5.31
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 5.31
STX4 Over-Expression in Human islets 5.28
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.24
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.17
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.12
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.1
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.1
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.06
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.97
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.97
Dilated cardiomyopathy vs Myocarditis 4.9
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.82
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 4.8
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.79
Human embryonic stem cells in E8 and AKIT culture medium 4.79
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.77
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 4.7
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.68
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 4.61
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 4.61
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.48
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.48
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.44
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.43
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.38
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.09
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 4.08
Tpl-2 small molecule project 3.91
Tpl-2 and MEK small molecule inhibitors 3.91
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.86
RNA-seq of cancer cell lines treated with T-025 3.83
Transcriptome analysis of virus infected tissues 3.81
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 3.72
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 3.69
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 3.67
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.58
Common inflammatory pathways between NEC and Crohn's disease 3.56
JAK dependent survival of ALK- ALCL 3.47
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.42
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.38
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.34
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.25
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 3.25
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.25
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 3.22
The contribution of Alu exons to the human proteome 3.18
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.16
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.07
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.07
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.96
Gene expression analysis of human hepatocellular cancers 2.95
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.93
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.72
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.69
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.55
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.55
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.4
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.18
The age and genomic integrity of neurons after cortical stroke in humans 2.15
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.14
Gene expression activation in CLL mediated by MSCs contact 2.14
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.13
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.1
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.08
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.01
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.98
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.95
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.91
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.86
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.85
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.85
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.85
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.82
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 1.82
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.82
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.82
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.79
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 1.77
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.72
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.7
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.7
HEK293 Heat-shock experiment 1.7
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.63
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.63
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.58
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.58
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.57
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.5
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.5
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.45
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.39
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.38
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.3
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.3
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.3
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.27
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.25
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.2
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.15
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.06
CD74 role in transcription regulation [RNA-seq] 1.05
CD74 role in transcription regulation 1.05
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.02
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 1.01
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.94
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.94
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.88
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.87
Human Tfh cell RNA bulk sequencing 0.86
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.86
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.84
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.83
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.83
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.83
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.74
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.71
RNA seq comparison between scrambled and shGRP78 cells 0.69
Interphase condensins regulate ligand-depedent enhancer activation 0.69
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.69
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.68
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.65
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.65
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.62
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.59
siRNA-mediated knockdown 0.54
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.52
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.47
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.47
iPSC derived motor neuron cultures from C9ORF72 carriers 0.43
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.38
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.37
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.37
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.35
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.31
Modulation of nonsense-mediated decay by rapamycin 0.31
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.31
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.28
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.27
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.25
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.23
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.21
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.21
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.16
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.14
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.14
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 0.13
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.12
The transcriptome of Kawasaki Disease arteritis 0.1
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.08
p63 controls the enhancer landscape during keratinocyte differentiation 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.03
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation